2025
article
OpenAlex
Anders L. Carlson, JAMES THRASHER, Anuj Bhargava, David C. Klonoff et autres
Introduction and Objective: MiniMedTM 780G (MM780G) advanced hybrid closed loop (AHCL) therapy with the Guardian™ 4 sensor demonstrated significantly improved A1C, increased time in range (%TIR, 70-180mg/dL) and tight range (%TITR, 70-140mg/dL), with no increase in time below range (%TBR, <70mg/dL), in …
2025
article
OpenAlex
Anders L. Carlson, Francisco J. Pasquel, GEORGIA M. DAVIS, DAVID M. HUFFMAN et autres
Introduction and Objective: The SECURE-T2D pivotal trial recently demonstrated safety and efficacy of the Omnipod® 5 Automated Insulin Delivery (AID) System in adults with insulin-treated T2D. This sub-analysis evaluated outcomes in participants previously using basal without bolus insulin. Methods: This multicenter 305-participant …
2025
article
OpenAlex
KRISTIN N. CASTORINO, Francisco J. Pasquel, GEORGIA M. DAVIS, DAVID M. HUFFMAN et autres
Introduction and Objective: AID can alleviate some of the burden associated with diabetes self-care and improve quality of life for people with diabetes; however, prior research has largely focused on type 1 diabetes. This analysis of the SECURE-T2D study evaluated the impact …
2024
article
OpenAlex
Francisco J. Pasquel, GEORGIA M. DAVIS, DAVID M. HUFFMAN, Anne L. Peters et autres
Background: There is limited experience with automated insulin delivery (AID) in Type 2 Diabetes (T2D). Methods: We conducted a multicenter pivotal clinical trial to evaluate use of the Omnipod 5 AID System in a large diverse group of adults with T2D in …
2024
article
OpenAlex
Ashley Thorsell, WENDY C. BEVIER, KRISTIN N. CASTORINO, David Kerr et autres
Hispanic/Latino (H/L) adults are disproportionately affected and have suboptimal control of Type 2 Diabetes (T2DM). We hypothesize that use of a Spanish-language smartphone application with structured blood glucose (BG) monitoring and proactive diabetes coaching (mySugr® PRO) will improve diabetes self-efficacy, weight, and …
2022
article
OpenAlex
SHRIDHARA A. KARINKA, RONALD L. BRAZG, KRISTIN N. CASTORINO, DAVID R. LILJENQUIST et autres
FreeStyle Libre 3 is the next generation FreeStyle Libre system with the same sensor tail but an on-body component that is about 70% smaller than Libre 2. We evaluated the accuracy of the FreeStyle Libre 3 system in people with diabetes ages …
2022
article
OpenAlex
WENDY C. BEVIER, Samuel R. LaMunion, MEGAN ROACH, NAMINO M. GLANTZ et autres
While physical activity (PA) improves physical health, and wearable accelerometers clarify PA behavior, patterns of PA and cardiometabolic risk have not been well studied in ethnic minorities. In the Mil Familias observational cohort study of Hispanic/Latino adults with or at risk for …
2022
article
OpenAlex
Bruce W. Bode, TIMOTHY S. BAILEY, KRISTIN N. CASTORINO, MARK P. CHRISTIANSEN et autres
Objective: A CGM sensor that is disposable and requires no calibration may make glucose management easier for people living with diabetes. The present study reports on the interim analysis of a new disposable zero-calibration sensor in adults and youth with type 1 …
2022
article
OpenAlex
WENDY C. BEVIER, HANQING LIU, KRISTIN N. CASTORINO, David Kerr
Long-haul travel (flights >6 hours) can be very disruptive for people living with type 1 diabetes (T1D) . As part of a study comparing long-acting basal insulins during long-haul travel (Bevier & Castorino, et al) , we evaluated the impact of direction …